ABSTRACT Background: In 2007 the World Cancer Research Fund Report concluded that there was limited and inconsistent evidence for an effect of coffee and tea consumption on the risk of epithelial ovarian cancer (EOC). Objective: In the European Prospective Investigation into Cancer and Nutrition (EPIC), we aimed to investigate whether coffee intakes, tea intakes, or both are associated with the risk of EOC. Design: All women participating in the EPIC (n = 330,849) were included in this study. Data on coffee and tea consumption were collected through validated food-frequency questionnaires at baseline. HRs and 95% CIs were estimated by using Cox proportional hazards models. Furthermore, we performed an updated meta-analysis of all previous prospective studies until April 2011 by comparing the highest and lowest coffee-and tea-consumption categories as well as by using dose-response random-effects meta-regression analyses. Results: During a median follow-up of 11.7 y, 1244 women developed EOC. No association was observed between the risk of EOC and coffee consumption [HR: 1.05 (95% CI: 0.75, 1.46) for the top quintile compared with no intake] or tea consumption [HR: 1.07 (95% CI: 0.78, 1.45) for the top quintile compared with no intake]. This lack of association between coffee and tea intake and EOC risk was confirmed by the results of our meta-analysis. Conclusion: Epidemiologic studies do not provide sufficient evidence to support an association between coffee and tea consumption and risk of ovarian cancer.
INTRODUCTION
The World Cancer Research Fund report of 2007 concluded that the evidence for an association between the consumption of coffee and tea and risk of ovarian cancer was limited and inconsistent (1) . In the same year, 2 meta-analyses were published, one on the consumption of tea and the other on the consumption of both coffee and tea (2, 3) . The meta-analysis of Steevens et al (2) comprised more studies than, and overlaps completely with, the meta-analysis of Zhou et al (3) . Therefore, from this point, we refer only to the meta-analysis of Steevens et al (2) . In this metaanalysis, the observed associations with ovarian cancer were weak and insignificant. However, when only prospective studies were considered, a significant decreased risk was observed with higher tea intake, whereas borderline significant increased risk was observed for higher consumption of coffee (2) . 1 To further clarify whether coffee and tea intake influence ovarian cancer risk, we investigated the association between these widely consumed beverages and risk of epithelial ovarian cancer (EOC) 5 in the European Prospective Investigation into Cancer and Nutrition (EPIC), which is the largest prospective cohort study to investigate this association to date. Moreover, we updated the meta-analysis of Steevens et al (2) with 3 cohort studies published after the reports of 2007 and the EPIC.
SUBJECTS AND METHODS

Study population
The EPIC is a multicenter prospective study aimed at investigating the relations between diet, lifestyle, and genetic and environmental factors and the incidence of cancer and other chronic diseases. The study cohort consists of subcohorts recruited from 23 centers in the following 10 European countries: Denmark, France, Germany, Greece, Italy, Netherlands, Norway, Spain, Sweden, and the United Kingdom. Between 1992 and 2000, a total of 519,978 men and women were recruited. Of these recruits, most subjects were aged 25-70 y and recruited from the general population. Exceptions were the Oxford cohort, United Kingdom (on the basis of vegetarian volunteers and healthy eaters); the Utrecht cohort, Netherlands (on the basis of women attending breast cancer screening); the French cohort (on the basis of female members of the health insurance for state school employees); and components of the Italian and Spanish cohorts (members of local blood donor associations). Eligible subjects who decided to participate signed an informed consent form and completed diet and lifestyle questionnaires, which were either interviewer administered (Naples, Ragusa, Spain, and Greece) or mailed and self-administered (all other centers). In most countries, participants were invited to a center for blood collection and anthropometric measurements. A full description of the study design and cohort has been published elsewhere (4, 5) .
Our study is based on data from the 330,849 female participants after a priori exclusion of women with prevalent malignancy (other than nonmelanoma skin cancer; n = 19,707), incomplete follow-up data (n = 2205), and history of bilateral oophorectomy at baseline (n = 10,500). Moreover, we excluded women with missing dietary (n = 2711) and lifestyle data (n = 526) as well as women who reported a daily consumption of .6 times the SD of coffee (n = 352) or tea (n = 241) per day.
Exposure assessment
Diet over the previous 12 mo was assessed at recruitment by using validated country-specific food-frequency questionnaires designed to ensure high compliance and improved measurement of local dietary habits (4, 6) . On the basis of the recorded number of cups of coffee and tea consumed per day, week, or month, the total consumption in milliliters per day was calculated at baseline. This conversion was done in each center and not centrally because cup sizes varied by region. The structure and availability of questions varied per center. As a consequence, questions regarding tea consumption were missing for Norway, and additional questions on caffeinated and decaffeinated coffee consumption were asked by only some of the centers (data on caffeinated coffee was not available for Ragusa, Naples, Umeå, and Denmark; data on decaffeinated coffee was not available for Sweden, Spain, Denmark, and Norway).
Information on reproductive data, physical activity, smoking status, educational level, and other lifestyle-related factors was collected from the baseline questionnaire. Weight and height were measured at recruitment, except for part of the Oxford cohort, the Norwegian cohort, and approximately twothirds of the French cohort, in whom weight and height were self-reported.
Determination of menopausal status
Women were considered as premenopausal at baseline if they reported having had regular menses over the past 12 mo or were ,46 y of age. Women were considered postmenopausal if they reported not having had any menses over the past 12 mo or were .55 y of age. Women who were between 46 and 55 y of age and had missing or incomplete questionnaire data for menopausal status were classified as perimenopausal or unknown.
Endpoints
The follow-up was based on either population-based cancer registries or a combination of methods including health insurance records, cancer and pathology registries, and active follow-up through study participants and their next of kin. Mortality data were also obtained from either the cancer registry or mortality registries at the regional or national level. We used the International Classification of Diseases, 10th Revision, for injuries and causes of death. Incident EOCs (borderline and invasive) were defined as C569, C570, or C48 (ie, ovarian, fallopian tube, or primary peritoneal cancers, respectively).
Data analysis
Person-years at risk were calculated from the start of the study until censoring at the date of diagnosis of ovarian cancer, death, emigration, other loss to follow-up or the date at which follow-up ended, which was defined as the last date at which follow-up data were judged to be complete or the last date of contact in the centers that used active follow-up.
To account for the large variation in volume and concentration between countries, country-specific quintiles (coffee and tea) and tertiles (caffeinated and decaffeinated coffee) were calculated for each beverage after exclusion of nonconsumers. HRs and their corresponding 95% CIs were estimated on the basis of Cox proportional hazards models by using age as the underlying time variable and stratified by center and age at recruitment (1-y intervals). We stratified by center to control for center effects related to different follow-up procedures and questionnaire designs. The following 3 models are presented: 1) a crude model; 2) a multivariate model adjusted for parity (number of full-term pregnancies), duration of oral contraceptive (OC) use (continuous), BMI (continuous), smoking status (never, current, or former), alcohol intake (continuous), and total energy intake (continuous); and 3) a third model with additional adjustment for duration of breastfeeding (continuous), menopausal status (premenopausal, perimenopausal, or postmenopausal), height (continuous), and educational level (none, primary school, technical or professional school, secondary school, or university). Because a modifying role of menopausal status in the association between coffee consumption and ovarian cancer risk has been observed in other studies, we performed subgroup analyses by menopausal status (7) (8) (9) . Also, we performed an additional subgroup analysis by the use of hormone therapy (HT; ever or never). Moreover, because the association between coffee and tea consumption might differ by smoking status, we also performed subgroup analyses by smoking status. Heterogeneity between these subgroups was tested by adding multiplicative interaction terms to the models and by using likelihood ratio tests for interactions. In addition, we performed analyses restricted to serous EOC cases. Also, we performed a sensitivity analysis by excluding EOC cases diagnosed in the first 2 y of follow-up. In addition, we also conducted analyses in which categories were based on absolute volumes consumed rather than country distributions. All statistical analyses were carried out with SAS 9.2 software (SAS Institute Inc). 
Meta-analysis
We conducted a meta-analysis of all prospective reports until April 2011, including 3 studies (9-11) published after the metaanalysis by Steevens et al (2) and EPIC data.
Search strategy
We searched PubMed (http://www.ncbi.nlm.nih.gov/pubmed) and EMBASE (http://www.embase.com/) (all years) for all relevant papers by using the keywords or Medical Subject Headings "ovarian" AND "cancer OR carcinoma OR tumor OR tumor OR neoplasm" combined with "coffee," "caffeine," or "tea." Moreover, we searched any additional studies in reference lists of retrieved articles.
Study selection
Studies were included in the meta-analysis if they met the following criteria: 1) studies were prospective studies; 2) frequency and amount of tea or coffee consumption were provided; 3) exposures of interest were total coffee, caffeinated coffee, decaffeinated coffee, or tea consumption; 4) the number of cases and person-years were provided; and 5) the outcome of interest was sporadic ovarian cancer. In the case of overlapping reports, only one study was retained.
Data extraction
We extracted the following information from each study: the first author's last name, publication year, study design, country of origin, cohort size, number of cases, beverage type, comparison categories, person-years, multivariate adjusted HRs or RRs and their corresponding 95% CIs, and variables that were adjusted for in the multivariate analyses.
Data analysis
We first performed a meta-analysis by comparing the highest and the lowest coffee-and tea-consumption categories. Pooled HRs were calculated on the basis of random-effects models. Statistical heterogeneity in studies was evaluated by using the I 2 statistic. Sensitivity analyses were performed by confounder adjustment (adjusted for parity and OC use or not). The potential for publication bias was examined by drawing a funnel plot and assessing its symmetry by using the Egger's test (12) . A significant asymmetry (P , 0.05) indicated the presence of a publication bias.
Subsequently, we conducted a dose-response, random-effects, meta-regression analysis from the correlated ln of HRs across categories of coffee and tea consumption by using the method proposed by Greenland and Longnecker (13) and Orsisni et al (14) . For each study we assigned the midpoint of the upper and lower bounds in each category as the average intake to each corresponding HR. If the upper bound in the highest category was not provided, we assumed that it had the same amplitude as the preceding category. Because we did not have data available on the number of cups per day for the EPIC, we were not able to include our own study in this analysis. Analyses were performed with Stata software (version 11.1; Stata Corp).
RESULTS
EPIC
In the 330,849 eligible women in this cohort, a total of 1244 women were diagnosed with primary incident EOC during a median follow-up of 11.7 y. Of these 1244 women, 1216 women (93.0%) were diagnosed with ovarian tumors, 43 women (3.3%) were diagnosed with peritoneal tumors, and 49 women (3.8%) were diagnosed with fallopian tube tumors. One-half of tumors (50.4%) were of serous origin, 9.8% of tumors were mucinous, 10.1% of tumors were endometrioid, and 4.2% of tumors were clear cell carcinomas. For all other tumors (25.5%), the origin was not known.
Numbers of cases, person-years, and the median consumption of coffee and tea in each category and by country are shown in Table 1 . Baseline characteristics of participants by coffee and tea consumption are presented in Table 2 . Compared with women who do not consume coffee, women in the highest quintile of coffee consumption were slightly younger, were taller, had higher BMI, and were more likely to be smokers, more likely to be physically active, less likely to be postmenopausal, and more likely to have used OCs and HT. Compared with women who did not consume tea, women in the highest quintile of tea consumption were slightly younger, were taller, had lower BMI, and were less likely to be smokers, more likely to be physically active, and more likely to have used OCs and HT.
Associations between coffee and tea consumption and risk of ovarian cancer are shown in Table 3 . Coffee consumption was not associated with risk of EOC [HR: 1.05 (95% CI: 0.75, 1.46) for the top quintile compared with no intake; P-trend = 0.43]. There was no evidence for an effect modification by menopausal status, use of HT, or smoking status (P-interaction = 0.78, 0.33, and 0.85, respectively).
No association was observed between tea consumption and risk of EOC [HR: 1.07 (95% CI: 0.78, 1.45) for the top quintile compared with no intake; P-trend = 0.83; Table 3 ]. Again, there was no evidence for an effect modification by menopausal status, use of HT, or smoking status (P-interaction = 0.35, 0.37, and 0.09, respectively).
Results remained similar after mutual adjustment for coffee and tea consumption in a multivariate model [HR: 1.11 (95% CI: 0.76, 1.63) for the top quintile of coffee consumption compared We also examined the association between coffee and tea intake and risk of ovarian cancer by using EPIC-wide quintiles rather than country-specific quintiles (data not shown 
Meta-analysis of previous prospective cohort studies
We identified a total of 5 relevant prospective studies on coffee consumption (2, 10, 11, 15-17) and 6 on tea consumption (2, 9, 16, (18) (19) (20) , including 3 studies (9-11) published after the metaanalysis by Steevens et al (2) . The studies of Gates et al (20) and Tworoger et al (9) had study populations that substantially overlapped. Therefore, only the most recent study was retained (9) . Characteristics of the studies included are provided in Table 5 . We were unable to analyze the results of studies on caffeinated and decaffeinated coffee intake because only 2 prospective studies have been published (9, 10) . The coffee consumed in all other studies that were not stratified for caffeinated and decaffeinated coffee consumption was expected to consist mainly of caffeinated coffee. Therefore, in our meta-analysis we used the results on caffeinated coffee consumption of the studies by Tworoger et al (9) and Lueth et al (10). Egger's tests for publication bias showed no significant asymmetry (t = 1.81, P = 0.13), which suggested that no publication bias was present. There was some heterogeneity across studies that investigated coffee consumption (I 2 = 50.9%, P = 0.06). When we pooled results from previous prospective studies, we observed a nonsignificant positive association between the consumption of coffee (highest compared with lowest categories) and risk of EOC (HR: 1.16; 95% CI: 0.86, 1.57; Figure 1 ). The association remained essentially the same after inclusion of the EPIC (HR: 1.13; 95% CI: 0.89, 1.43). Moreover, results did not change after the exclusion of the study of Nilsson et al (11) that did not adjust for parity or OC use (HR: 1.12; 95% CI: 0.87, 1.44). Our doseresponse, random-effects, meta-regression analysis, which did not include the EPIC, showed that an increment of one cup of coffee per day was not associated with risk of EOC (HR: 1.02; 95% CI: 0.99, 1.05).
For studies on tea consumption, we also did not observe evidence of publication bias (Egger's t = 1.06, P = 0.35). We observed minor heterogeneity in these studies (I 2 = 31.8%, P = 0.20). The pooled HR for previous prospective studies showed Figure 2 ). The association remained essentially the same after inclusion of the EPIC (HR: 0.88; 95% CI: 0.71, 1.09). In addition, results remained similar after exclusion of the study of Zheng et al (19) that did not adjust for parity and OC use (HR: 0.86; 95% CI: 0.67, 1.10). Our dose-response, randomeffects, meta-regression analysis showed that an increment of one cup of tea per day was not significantly associated with risk of EOC (HR: 0.95; 95% CI: 0.87, 1.04; the EPIC was not included).
DISCUSSION
In this large prospective cohort study, we did not find any association of consumption of total, caffeinated, and decaffeinated coffee and tea with risk of ovarian cancer. The lack of association for total coffee consumption in our study was confirmed by our meta-analysis of prospective cohort studies, which also showed no association between the consumption of coffee and risk of ovarian cancer. Moreover, the pooling of results of case-control studies, as was done in the meta-analysis by Steevens et al (2) also did not result in significant findings. Furthermore, our results were in line with a recently published meta-analysis of cohort studies that assessed the association between coffee consumption and risk of total cancer as well as risk of several cancer sites, including ovarian cancer (21) . We also did not observe an association between the consumption of caffeinated and decaffeinated coffee and risk of ovarian cancer. Results from other studies on caffeinated coffee consumption have been inconsistent, with some studies that showed no association (22, 23) and other studies that showed an inverse (7, 10) or positive (9) association. Although our lack of association with decaffeinated coffee was in line with most studies (7, 9, 10, 22, 23) , 2 studies showed an inverse association (24, 25) . Coffee contains many bioactive compounds including phenolic acids with strong antioxidant properties and cafestol and kahweol with anticarcinogenic activity (26) . Moreover, several commercially prepared coffee brews have been associated with antiproliferation activities against human ovarian cancer cells (27) . In contrast, coffee also contains acrylamide and caffeine, which have potential hormonal and carcinogenic effects (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) . However, the results of our study and our meta-analysis implied that there is no evidence for an association between the consumption of coffee and risk of ovarian cancer. Finally, this implication is consistent with the conclusion of the World Cancer Research Fund (1).
We did not observe an association between tea consumption and risk of EOC in the EPIC. Although this result is in contrast with the previously published meta-analysis by Steevens et al (2) , the reverse association between tea intake and EOC risk was no longer significant in our meta-analysis of prospective studies. Because the EPIC is the largest prospective study to date, and is larger than the combination of all other prospective studies published to date, our negative finding largely influenced this result. In contrast, our results on tea consumption might be less comparable with other studies because we assessed the association between quintiles of intake compared with the number of cups per day in other studies. However, the results of our metaanalysis remained similar when including or excluding EPIC data. Therefore, although we could not completely rule out that tea intake protects against EOC risk, our results did not confirm this association.
A potential protective role of tea might be the result of the antioxidant activity of tea because tea is a rich source of antioxidant polyphenols, such as catechins, flavanols, theaflavins, and therubigens (26, (38) (39) (40) . Moreover, human studies have shown that these polyphenols protect against carcinogenesis (38, 39, 41) . Epigallocatechin gallate shown primarily in green tea, and theaflavin digallate, which is a major component of black tea, are the 2 most effective anticancer factors found in tea (38) .
A major strength of this large cohort study was the prospective design, with detailed exposure and covariate assessment before diagnosis. The EPIC cohort consists of multiple populations with a wide range of variation in dietary patterns. Because the volume and concentration of coffee and tea consumption differ to a large extent between different European countries, we calculated country-specific quintiles and tertiles of consumption to reduce misclassification, which might have diluted some of the effects. However, our results were confirmed by the sensitivity analyses by using EPIC-wide quintiles. Finally, as previously stated, this study is the largest prospective study published on this association to date and is larger than all previously published prospective studies combined.
A limitation of our study was the lack of information on brewing methods, preparation, cup size, and duration of use. However, a recent study by Nilsson et al (11) did not observe clear differences between the effect of boiled and filtered coffee on risk of ovarian cancer. With regard to the consumption of tea, it is expected that mostly black tea is consumed in European countries (1, 42) . Also, although we adjusted our analysis for a broad range of potential confounding factors, there is still a chance of unmeasured or residual confounding. We have, for instance, adjusted for smoking status, which did not incorporate smoking intensity and duration. Another limitation was that our study lacked statistical power to stratify by histologic subtypes. Strengths of our meta-analysis included its systematic search for publications, the inclusion of only prospective studies, and the investigation of a possible dose-response relation. Some limitations of our meta-analysis should be acknowledged as well. First, because the categories of low and high consumption varied across different studies, the overall estimates for high consumption were based on study-specific definitions and might not be perfectly comparable. Second, because only observational studies were included, confounding was not controlled for by randomization and therefore residual confounding might still have existed. In conclusion, this large, prospective cohort study and metaanalysis did not find evidence of an association between the consumption of coffee and tea and risk of ovarian cancer.
